{"status": "Ok", "redirect_url": "https://www.businesswire.com/news/home/20260610500156/en/Genmab-Presents-EPCORE%C2%AE-FL-1-Subgroup-Data-Demonstrating-Consistent-Efficacy-and-Safety-Results-for-Epcoritamab-in-Combination-with-Rituximab-and-Lenalidomide-R2-Across-Relapsed-or-Refractory-RR-Follicular-Lymphoma-FL-Patients", "message": "News view counter 793614 successfully enlarged"}